Up a level |
Naeem, Abdulghani A, Abdulsamad, Saud A, Zeng, Hao, He, Gang, Jin, Xi, Zhang, Jiacheng, Alenezi, Bandar T, Ma, Hongwen, Rudland, Philip S ORCID: 0000-0002-7491-0846 and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2024)
FABP5 can substitute for androgen receptor in malignant progression of prostate cancer cells.
International journal of oncology, 64 (2).
18-.
Alenezi, Bandar T, Alsubhi, Mohammed H, Jin, Xi, He, Gang, Wei, Qiang and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2021)
Global Development on Causes, Epidemiology, Aetiology, and Risk Factors of Prostate Cancer: An Advanced Study.
Highlights on Medicine and Medical Science, 17.
pp. 94-117.
Zhang, Jiacheng, He, Gang, Jin, Xi, Alenezi, Bandar T, Naeem, Abdulghani A, Abdulsamad, Saud A and Ke, Youqiang ORCID: 0000-0001-5341-8644
(2023)
Molecular mechanisms on how FABP5 inhibitors promote apoptosis-induction sensitivity of prostate cancer cells.
Cell biology international, 47 (5).
pp. 929-942.